AMEX : ASXC
$0.0 (0.64%)
AMEX
Anthony Fernando
Medical - Devices
Healthcare
ASXC
207
US
USD
0.17
2.88
2.31
1.35
0.00
$8.58M
11.07
2.60
-1.48
-0.26
-$0.31
-$78.43M
-914.46%
-910.80%
-117.89%
-129.57%
-1.12
-0.13
-0.13
$1.50
$1.50
$1.50
0/5
2 Analysts
-76.81%
-41.91
3/9
-$20.48M
$38.5M
$49.83M
-$78.82M
$83.51M
9.74
-1.12
2.88
-117.89%
-159.01%
-90.29%
-67.62%
233 days
| Name | Title |
|---|---|
| Ethan Loiselle | Vice President of Global Marketing |
| Joshua Weingard | Chief Legal Officer & Secretary |
| Motti Frimer | Vice President of R&D, Digital Solutions and MD of Asensus Surgical |
| Ravi Kommineni | Head of Global Quality & Regulatory |
| Amanda Owens | Vice President of People |
| Anthony Fernando | President, Chief Executive Officer & Director |
| Shameze Rampertab | Executive Vice President & Chief Financial Officer |
No votes yet today — be the first to share your view!
About Asensus Surgical, Inc. (AMEX:ASXC) Stock
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuv ... er up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Frequently Asked Questions
What is the current Asensus Surgical, Inc. (ASXC) stock price?
Asensus Surgical, Inc.(AMEX:ASXC) stock price is $0.3479 in the last trading session. During the trading session, ASXC stock reached the peak price of $0.3993 while $0.169 was the lowest point it dropped to. The percentage change in ASXC stock occurred in the recent session was 0.64% while the dollar amount for the price change in ASXC stock was $0.0.
ASXC's industry and sector of operation?
The AMEX listed ASXC is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of ASXC?
Ethan Loiselle
| Vice President of Global Marketing
Joshua Weingard
| Chief Legal Officer & Secretary
Motti Frimer
| Vice President of R&D, Digital Solutions and MD of Asensus Surgical
Ravi Kommineni
| Head of Global Quality & Regulatory
Amanda Owens
| Vice President of People
How many employees does ASXC have?
Number of ASXC employees currently stands at 207. ASXC operates from 1 TW Alexander Drive, Durham, NC 27703, US.
Link for ASXC official website?
Official Website of ASXC is: https://www.asensus.com
How do I contact ASXC?
ASXC could be contacted at phone #919 765 8400 and can also be accessed through its website. ASXC operates from 1 TW Alexander Drive, Durham, NC 27703, US.
How many shares of ASXC are traded daily?
The average number of ASXC shares traded daily for last 3 months was 3.06M.
What is the market cap of ASXC currently?
The market value of ASXC currently stands at $94.92M with its latest stock price at $0.3479